Literature DB >> 22035663

Target volume delineation in oropharyngeal cancer: impact of PET, MRI, and physical examination.

Anuradha Thiagarajan1, Nicola Caria, Heiko Schöder, N Gopalakrishna Iyer, Suzanne Wolden, Richard J Wong, Eric Sherman, Matthew G Fury, Nancy Lee.   

Abstract

INTRODUCTION: Sole utilization of computed tomography (CT) scans in gross tumor volume (GTV) delineation for head-and-neck cancers is subject to inaccuracies. This study aims to evaluate contributions of magnetic resonance imaging (MRI), positron emission tomography (PET), and physical examination (PE) to GTV delineation in oropharyngeal cancer (OPC).
METHODS: Forty-one patients with OPC were studied. All underwent contrast-enhanced CT simulation scans (CECTs) that were registered with pretreatment PETs and MRIs. For each patient, three sets of primary and nodal GTV were contoured. First, reference GTVs (GTVref) were contoured by the treating radiation oncologist (RO) using CT, MRI, PET, and PE findings. Additional GTVs were created using fused CT/PET scans (GTVctpet) and CT/MRI scans (GTVctmr) by two other ROs blinded to GTVref. To compare GTVs, concordance indices (CI) were calculated by dividing the respective overlap volumes by overall volumes. To evaluate the contribution of PE, composite GTVs derived from CT, MRI, and PET (GTVctpetmr) were compared with GTVref.
RESULTS: For primary tumors, GTVref was significantly larger than GTVctpet and GTVctmr (p < 0.001). Although no significant difference in size was noted between GTVctpet and GTVctmr (p = 0.39), there was poor concordance between them (CI = 0.62). In addition, although CI (ctpetmr vs. ref) was low, it was significantly higher than CI (ctpet vs. ref) and CI (ctmr vs. ref) (p < 0.001), suggesting that neither modality should be used alone. Qualitative analyses to explain the low CI (ctpetmr vs. ref) revealed underestimation of mucosal disease when GTV was contoured without knowledge of PE findings. Similar trends were observed for nodal GTVs. However, CI (ctpet vs. ref), CI (ctmr vs. ref), and CI (ctpetmr vs. ref) were high (>0.75), indicating that although the modalities were complementary, the added benefit was small in the context of CECTs. In addition, PE did not aid greatly in nodal GTV delineation.
CONCLUSION: PET and MRI are complementary and combined use is ideal. However, the low CI (ctpetmr vs. ref) particularly for primary tumors underscores the limitations of defining GTVs using imaging alone. PE is invaluable and must be incorporated. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22035663     DOI: 10.1016/j.ijrobp.2011.05.060

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  24 in total

Review 1.  Functional magnetic resonance imaging of head and neck cancer: Performance and potential.

Authors:  Ahmed H El Beltagi; Ahmed H Elsotouhy; Ahmed M Own; Wael Abdelfattah; Kavitha Nair; Surjith Vattoth
Journal:  Neuroradiol J       Date:  2018-11-06

2.  Interobserver and intermodality variability in GTV delineation on simulation CT, FDG-PET, and MR Images of Head and Neck Cancer.

Authors:  Carryn M Anderson; Wenqing Sun; John M Buatti; Joan E Maley; Bruno Policeni; Sarah L Mott; John E Bayouth
Journal:  Jacobs J Radiat Oncol       Date:  2014-09

Review 3.  Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: the point of view of the radiation oncologist.

Authors:  Jon Cacicedo; Arturo Navarro; Olga Del Hoyo; Alfonso Gomez-Iturriaga; Filippo Alongi; Jose A Medina; Olgun Elicin; Andrea Skanjeti; Francesco Giammarile; Pedro Bilbao; Francisco Casquero; Berardino de Bari; Alan Dal Pra
Journal:  Br J Radiol       Date:  2016-08-02       Impact factor: 3.039

4.  Segmentation of parotid glands from registered CT and MR images.

Authors:  Domen Močnik; Bulat Ibragimov; Lei Xing; Primož Strojan; Boštjan Likar; Franjo Pernuš; Tomaž Vrtovec
Journal:  Phys Med       Date:  2018-06-19       Impact factor: 2.685

Review 5.  Radiotherapy for head and neck tumours in 2012 and beyond: conformal, tailored, and adaptive?

Authors:  Vincent Grégoire; Robert Jeraj; John Aldo Lee; Brian O'Sullivan
Journal:  Lancet Oncol       Date:  2012-06-28       Impact factor: 41.316

6.  18F-Fluorodeoxyglucose-PET/CT in locally advanced head and neck cancer can influence the stage migration and nodal radiation treatment volumes.

Authors:  Rosario Mazzola; Pierpaolo Alongi; Francesco Ricchetti; Alba Fiorentino; Sergio Fersino; Niccolò Giaj-Levra; Matteo Salgarello; Filippo Alongi
Journal:  Radiol Med       Date:  2017-08-28       Impact factor: 3.469

Review 7.  Functional magnetic resonance imaging techniques and their development for radiation therapy planning and monitoring in the head and neck cancers.

Authors:  Jing Yuan; Gladys Lo; Ann D King
Journal:  Quant Imaging Med Surg       Date:  2016-08

Review 8.  Current Standards for Organ Preservation in Locoregionally Advanced Non-nasopharyngeal Head and Neck Cancer and Evolving Strategies for Favorable-Risk and Platinum-Ineligible Populations.

Authors:  Susan Y Wu; Sue S Yom
Journal:  Curr Treat Options Oncol       Date:  2019-12-04

9.  A prognostic volumetric threshold of gross tumor volume in head and neck cancer patients treated with radiotherapy.

Authors:  Paul B Romesser; Muhammad M Qureshi; Rathan M Subramaniam; Osamu Sakai; Scharukh Jalisi; Minh T Truong
Journal:  Am J Clin Oncol       Date:  2014-04       Impact factor: 2.339

10.  Postoperative PET/CT and target delineation before adjuvant radiotherapy in patients with oral cavity squamous cell carcinoma.

Authors:  Pinaki R Dutta; Nadeem Riaz; Sean McBride; Luc G Morris; Snehal Patel; Ian Ganly; Richard J Wong; Frank Palmer; Heiko Schöder; Nancy Lee
Journal:  Head Neck       Date:  2015-09-03       Impact factor: 3.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.